However, such a combination of Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin was not being considered, Paul said at a press briefing.
A mix and match of Covid-19 vaccine doses is unlikely to happen in the country anytime soon, VK Paul, member-health, Niti Aayog, indicated on Saturday. Preliminary results from a trial in UK, where a combination of the Oxford-AstraZeneca and Pfizer-BioNTech Covid-19 vaccines were given, generated high immune response against the SARS-COV-2 virus.
However, such a combination of Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin was not being considered, Paul said at a press briefing. Mixing of vaccine doses was theoretically possible, but was not at a stage where it could be recommended, he pointed out.
“This was an evolving science and was not definitive,” Paul said, adding there was no robust scientific evidence to support, and call would be taken only after seeing how it evolves around the world and conducting more studies in the country.
Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.
Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.
Stay connected with us on social media platform for instant update click here to join our Twitter, & Facebook
We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.
For all the latest Life Style News Click Here
For the latest news and updates, follow us on Google News.
Denial of responsibility! NewsAzi is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.
